Top Markets
Coin of the day
MicroPort CardioFlow Medtech Corporation MicroPort CardioFlow Medtech Corporation

MicroPort CardioFlow Medtech Corporation

2160
株式のランク #22553
MicroPort CardioFlow Medtech Corporation is a medical technology firm dedicated... MicroPort CardioFlow Medtech Corporation is a medical technology firm dedicated to the comprehensive research, development, and commercialization of advanced transcatheter and surgical therapies for structural heart conditions. Operating primarily within the People's Republic of China, its innovative product line includes the Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, specifically engineered to treat aortic, mitral, tricuspid, and surgical valve disorders. The company also supplies a range of essential procedural accessories. MicroPort CardioFlow Medtech, which commenced operations in 2010, maintains its corporate headquarters in Shanghai, China.
株価
$0.1765382
最終同期: 2026-08-21
時価総額
$86.81M
変化(1日)
-0.36%
変化(1年)
-81.61%
CN
取引 MicroPort CardioFlow Medtech Corporation (2160)

カテゴリー

MicroPort CardioFlow Medtech Corporation(2160)の収益
Aug 2026 時点の収益 TTM: 0
MicroPort CardioFlow Medtech Corporation の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
MicroPort CardioFlow Medtech Corporation の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
- -
DE